Could a common heart drug boost cancer treatment? a trial puts propranolol to the test
Disease control
Not yet recruiting
This trial is investigating whether adding the beta-blocker propranolol to standard chemotherapy and immunotherapy before surgery can improve outcomes for people with resectable locally advanced gastric or gastroesophageal junction cancer. About 49 participants will receive the c…
Phase: PHASE1, PHASE2 • Sponsor: Ting Liu • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC